Endometrial hyperplasia precedes cancer, or endometrial malignancy, and it belongs to the most common bioptic methods of diagnoses. Endometrial hyperplasia mainly affects women aged about 60 who are after menopause. Highly differentiated carcinoma develops as a result of long-term hormonal effects, and it is likely to be cured. On the other hand, poorly differentiated carcinoma may occur unrelated to the hormonal production and its prognosis is very poor.
Penoxal aids an easier and faster recovery as it promotes immunity and thus reduces a risk of developing the disease; it balances the internal environment and it harmonises the reproductive organ activity. M.D. Anna Galambos, Pharm.Dr. Thomas Arndt and other doctors confirm in their statements about Penoxal that it is suitable food supplement to complement gynecological treatments. Find out more about Penoxal users experience HERE.
Apart from older age, there are many risk factors of endometrial hyperplasia. Those include obesity, diabetes and hypertension. Even delayed menopause in women aged over 50 is one of the risk factors. Moreover, if the woman’s body is compromised due to weak immune system, a chance of developing endometrial hyperplasia and the potential onset of cancer multiplies.
Women progressing towards menopause may experience irregular bleeding at a primary stage of potential diagnosis. In postmenopausal women any bleeding is a possible sign. Endometrial hyperplasia at advanced stage has very painful symptoms.
A primary preventative measure to endometrial hyperplasia is adherence to regular health checks at a gynaecologist’s. The hormonal balance and particularly the immune system have a great impact on endometrial malignancy. Hormones challenged by obesity have devastating effects on gynaecological problems, so it is necessary to follow a healthy and balanced diet. Targeted prevention from gynaecological and other diseases may be complemented by natural products that boost the immune system and ensure better immunity.
Diagnosis is usually established after the intervention called curettage, when a sample is taken and the bleeding ceases. It is impossible to diagnose endometrial hyperplasia by ultrasound. Simultaneously, hysteroscopy is performed to ensure a more in-depth assessment of the uterine cavity. If malignant endometrial tumour is found, the extent of the disease is determined and other organs are examined. Endometrial cancer treatment is done operatively via radiotherapy or hormonal therapy.
Endometrial hyperplasia is a gynaecological threat to women, but it may be stopped on time, provided the immune system is enhanced. Weak immunity is the greatest enemy of good health, so when strengthened by e.g. appropriate natural food supplements, endometrial hyperplasia and the potential malignancy can be prevented.